BALCHEM CORP

For the period ended Dec 31, 2024. Filed Feb 21, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 21, 2025

BCPC$173.54-1.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of December 31, 20 and

Consolidated Balance Sheets

December 31, 2024 and 2023

(Dollars in thousands, except share and per share data)

	2024	2023
Current assets:
Cash and cash equivalents	$49,515	$64,447
Accounts receivable, net of allowance for credit losses of $909 and $908 at December 31, 2024 and 2023, respectively	119,662	125,284
Inventories, net	130,802	109,521
Prepaid expenses	8,054	7,798
Other current assets	5,737	7,192
Total current assets	313,770	314,242
Property, plant and equipment, net	282,154	276,039
Goodwill	780,030	778,907
Intangible assets with finite lives, net	165,050	191,212
Right of use assets - operating leases	15,320	17,763
Right of use assets - finance lease	1,730	2,101
Other non-current assets	17,317	16,947
Total assets	$1,575,371	$1,597,211
Liabilities and Stockholders’ Equity
Current liabilities:
Trade accounts payable	$54,745	$55,503
Accrued expenses	43,750	40,855
Accrued compensation and other benefits	22,886	17,228
Dividends payable	28,510	25,717
Income tax payable	4,466	4,967
Operating lease liabilities - current	3,134	3,949
Finance lease liabilities - current	194	272
Total current liabilities	157,685	148,491
Revolving loan	190,000	309,569
Deferred income taxes	43,722	52,046
Operating lease liabilities - non-current	12,967	14,601
Finance lease liabilities - non-current	1,749	1,943
Other long-term obligations	19,335	16,577
Total liabilities	425,458	543,227
Commitments and contingencies (Note 16)
Stockholders’ equity:
Preferred stock, $25 par value. Authorized 2,000,000 shares; none issued and outstanding	—	—
Common stock, $.0667 par value. Authorized 120,000,000 shares; 32,527,244 shares issued and outstanding at December 31, 2024 and 32,254,728 shares issued and outstanding at December 31, 2023, respectively	2,170	2,152
Additional paid-in capital	173,997	145,653
Retained earnings	997,493	897,488
Accumulated other comprehensive (loss) income	(23,747)	8,691
Total stockholders’ equity	1,149,913	1,053,984
Total liabilities and stockholders’ equity	$1,575,371	$1,597,211

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.